Nifedipine Tablet, Extended Release
Product Images NDC 71610-841

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Nifedipine (NDC 71610-841). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (71610 0841 60)

Label (71610 0841 60)
This text provides information about a medication called Nifedipine ER, USP in the form of 30mg tablets. The packaging contains 90 tablets and is manufactured by Novast Laboratories Ltd. in Nantong, China, and packaged by Aphena Pharma in Cookeville, Tennessee. The NDC number for this product is 71610-841-60 and the GTIN is 1037110841602. The batch number is 1 and the serial number is P022485701. It is important to keep this medication and all drugs out of the reach of children.*
FDA Label Image

Aphena (Aphena)

FDA Label Image

Image1 (Image 01)

FDA Label Image

Image2 (Image 02)

Image2 (Image 02)
This text provides information on mean reductions in trough supine blood pressure (in mmHg) for systolic and diastolic readings with different doses of Nifedipine extended-release tablets from studies 1 and 2. The data shows how the blood pressure readings changed with the different doses of Nifedipine ER compared to placebo.*
FDA Label Image

Image3 (Image 03)

Image3 (Image 03)
This table provides data on the percentage of adverse effects experienced by patients taking nifedipine extended-release tablets compared to those taking placebo. Common adverse effects include headache, flushing/heat sensation, dizziness, fatigue/asthenia, nausea, and constipation. The study involved 370 patients in the nifedipine group and 126 patients in the placebo group.*
FDA Label Image

Image4 (Image 04)

Image4 (Image 04)
These are tablets of different strengths with color markings indicating the dosage. The tablets have either 30 mg, 60 mg, or 90 mg of active ingredient. They are marked with the Novast logo on one side and numbers 33, 36, or 39 on the other side to identify their respective strengths.*
FDA Label Image

Image5 (Image 05)

Image5 (Image 05)
This is a list detailing different bottle sizes and strengths of a medication identified by its NDC codes. The medication comes in bottles of 100 tablets with strengths of 30 mg, 60 mg, and 90 mg. The NDC codes for each are 50742-620-01, 50742-621-01, and 50742-622-01 respectively. These codes are used to uniquely identify the medication and dosage form for billing and tracking purposes.*
FDA Label Image

Image6 (Image 06)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.